£141.29

Infectious Diseases: Response, Recovery and Trends: Response, Recovery and Trends

Infectious & Contagious Diseases

Price data last checked 25 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

New to our records — first sighting 25 days ago. We'll learn its rhythm.

25 days of data · current price £141

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 1 days • 1 data points (No recent data available)

Historical

Generating forecast...

Not enough data points to display chart (need at least 2 points)

Price Distribution

Price distribution over 1 days • 1 price levels

Days at Price

Price Analysis

Most common price: £141 (1 days, 100.0%)

Price range: £141 - £141

Price levels: 1 different prices over 1 days

Description

An infectious disease threat is unique because of the transmissibility of diseases and the mobility of human populations. Infectious disease threats in recent years - such as Zika and Ebola outbreaks - have heightened the United States' attention to future potential threats, and raised questions about the nation's preparedness and response capabilities. Chapter 1 describes funding HHS has made available to awardees through its key preparedness and capacity-building programs-ELC, HPP, and PHEP; and these programs' performance measurement data on the awardees' infectious disease preparedness capacity. The World Health Organization (WHO) declared the Zika virus a public health emergency of international concern in February 2016. Zika virus disease can cause adverse pregnancy and neurological outcomes. Chapter 2 examines information on what is known and not known about the epidemiology of the Zika virus, and any challenges with conducting surveillance and epidemiological studies, characteristics of different diagnostic tests authorized during the outbreak, challenges test manufacturers and users faced, and the extent to which FDA and CDC followed their own communication guidance, and the strengths and limitations of available mosquito control methods, and challenges federal agencies face supporting these efforts. Chapter 3 describes the status of funds obligated and disbursed from the Zika supplemental funding appropriated to HHS and its agencies; and how selected awardees used their Zika supplemental funding, and their experiences with applying for and managing the funding. Chapter 4 examines the status of USAID and State funding for U.S. Zika response overseas, activities supported by these funds, and implementation challenges, if any, and responses to any challenges. The 2014-2015 Ebola outbreak in West Africa caused long-term second-order impacts, including disruptions to health systems, job loss, and food insecurity. As of September 30, 2017, of the $1.6 billion that the U.S. Agency for International Development (USAID) had obligated for the Ebola outbreak. Chapter 5 examines obligations for USAID's Ebola recovery projects, the status of USAID's implementation of these projects, and USAID's evaluation of Ebola recovery efforts. On August 1, 2018, the World Health Organization (WHO) reported a new Ebola outbreak in eastern DRC, about a week after declaring that a separate outbreak had ended in western DRC as reported in chapter 6. Between September 2018 and May 2019, the number of African swine fever (ASF) outbreaks has rapidly increased, most notably in China, triggering economic losses in affected pork-producing countries as discussed in chapter 7. As reported in chapter 9, Tuberculosis (TB) remains a major, and evolving, health challenge in many parts of the world and a priority for the U.S. Congress and international community. Congress has long taken an interest in infectious disease prevention and control. According to chapter 10, the measles, mumps, and rubella (MMR) vaccine is 97% effective in preventing infection and related deaths, and routine MMR vaccination is recommended for all children.

Product Specifications

Format: hardcover
ASIN: 1536164011
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Infectious & Contagious Diseases
Domain: Amazon UK
Release Date: 01 October 2019
Listed Since: 31 July 2019

Barcode

No barcode data available

Infectious Diseases: Response, Recovery and Trends: Response, Recovery and Trends

New to our records — first sighting 25 days ago. We'll learn its rhythm.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Zika Virus: Background, Issues, & U.S. Response Considerations (Virology Research Progress)

Emerging and Re-emerging Viral Infections: Advances in Microbiology, Infectious Diseases and Public Health Volume 6: 972 (Advances in Experimental Medicine and Biology, 972)

LECTURE NOTES ON EMERGING VIRUSES AND HUMAN HEALTH: A GUIDE TO ZOONOTIC VIRUSES AND THEIR IMPACT

Trends in Emerging Viral Infections of Swine

Wildlife and Emerging Zoonotic Diseases: The Biology, Circumstances and Consequences of Cross-Species Transmission: 315 (Current Topics in Microbiology and Immunology, 315)

Global Virology II - HIV and NeuroAIDS

Challenges in Infectious Diseases (Emerging Infectious Diseases of the 21st Century)

Emergence and Control of Zoonotic Viral Encephalitides (Archives of Virology Supplement 18)

Understanding the Spread of Infectious Diseases (Infectious Diseases and Microbiology)

Infectious Disease Surveillance

Pandemics and Polarization: Implications of Partisan Budgeting for Responding to Public Health Emergencies

New and Evolving Infections of the 21st Century (Emerging Infectious Diseases of the 21st Century)

COVID-19: Overview, Economic Implications and Federal Response (Public Health in the 21st Century)

Wildlife and Emerging Zoonotic Diseases: The Biology, Circumstances and Consequences of Cross-Species Transmission: 315 (Current Topics in Microbiology and Immunology, 315)

Handbook of Bioterrorism and Disaster Medicine

Chikungunya Virus: Advances in Biology, Pathogenesis, and Treatment

Emerging and Re-emerging Infectious Diseases of Livestock

Infectious Diseases, An Issue of Nursing Clinics (Volume 54-2) (The Clinics: Nursing, Volume 54-2)

Medical Virology 10: 10th (Medical Virology: International Symposium Proceedings)

Viral, Parasitic, Bacterial, and Fungal Infections: Antimicrobial, Host Defense, and Therapeutic Strategies

Emergency Management of Infectious Diseases

Infectious Disease Informatics: Syndromic Surveillance for Public Health and Bio-Defense: 21 (Integrated Series in Information Systems, 21)

Mathematical and Statistical Modeling for Emerging and Re-emerging Infectious Diseases

Toxoplasma gondii: Prevalence and Role in Health and Disease (Parasites and Parasitic Diseases): Biology and Role in Health and Disease